ID: ALA6577

Max Phase: Preclinical

Molecular Formula: C13H10O5

Molecular Weight: 246.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c2occc2c(CO)c2ccc(=O)oc12

Standard InChI:  InChI=1S/C13H10O5/c1-16-13-11-8(4-5-17-11)9(6-14)7-2-3-10(15)18-12(7)13/h2-5,14H,6H2,1H3

Standard InChI Key:  BMOUFGSYQMAJTB-UHFFFAOYSA-N

Associated Targets(Human)

NHIK3025 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.22Molecular Weight (Monoisotopic): 246.0528AlogP: 2.04#Rotatable Bonds: 2
Polar Surface Area: 72.81Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.02CX LogD: 1.02
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.70Np Likeness Score: 1.43

References

1. Hansen JB, Bjerring P, Buchardt O, Ebbesen P, Kanstrup A, Karup G, Knudsen PH, Nielsen PE, Nordén B, Ygge B..  (1985)  Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.,  28  (8): [PMID:4020822] [10.1021/jm00146a006]

Source